Ausgabe 7/2021
Inhalt (29 Artikel)
Ten–eleven translocase: key regulator of the methylation landscape in cancer
Jyoti Shekhawat, Kavya Gauba, Shruti Gupta, Bikram Choudhury, Purvi Purohit, Praveen Sharma, Mithu Banerjee
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression
Qingkang Meng, Yan Zhang, Guoqi Li, Yunong Li, Hongbo Xie, Xiujie Chen
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience
Giada Munari, Gianluca Businello, Paola Mattiolo, Gianmaria Pennelli, Marta Sbaraglia, Chiara Borga, Salvatore Pucciarelli, Gaya Spolverato, Claudia Mescoli, Francesca Galuppini, Antonio Sommariva, Elena Bellan, Sara Lonardi, Fotios Loupakis, Claudio Luchini, Angelo Paolo Dei Tos, Matteo Fassan
Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma
Jean-Baptiste Guy, Sophie Espenel, Safa Louati, Arnaud Gauthier, Max-Adrien Garcia, Nicolas Vial, Céline Malésys, Dominique Ardail, Gersende Alphonse, Anne-Sophie Wozny, Claire Rodriguez-Lafrasse, Nicolas Magné
Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes
Maja Tank, Kristina Franz, Emanuele Cereda, Kristina Norman
The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo
Xin He, Xiaoguang Ma, Congcong Wang, Mingchun Luan, Ying Li, Xiaohua Huang, Keli Ma
Correction to: The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo
Xin He, Xiaoguang Ma, Congcong Wang, Mingchun Luan, Ying Li, Xiaohua Huang, Keli Ma
Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients
Paulina Karin Grillo, Balázs Győrffy, Martin Götte
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Stefano Martellucci, Letizia Clementi, Samantha Sabetta, Paola Muzi, Vincenzo Mattei, Mauro Bologna, Adriano Angelucci
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers
Chrissie E. B. Ong, Amanda L. Patchett, Jocelyn M. Darby, Jinying Chen, Guei-Sheung Liu, A. Bruce Lyons, Gregory M. Woods, Andrew S. Flies
CCL5 production by fibroblasts through a local renin–angiotensin system in malignant melanoma affects tumor immune responses
Kenta Nakamura, Yukiko Kiniwa, Ryuhei Okuyama
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma
Shin Ishihara, Takeshi Iwasaki, Kenichi Kohashi, Yuichi Yamada, Yu Toda, Yoshihiro Ito, Yousuke Susuki, Kengo Kawaguchi, Dai Takamatsu, Shinichiro Kawatoko, Daisuke Kiyozawa, Taro Mori, Izumi Kinoshita, Hidetaka Yamamoto, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima, Yoshinao Oda
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
Yao Zhao, Chenchen Cai, Miaomiao Zhang, Lubing Shi, Jiwei Wang, Haoliang Zhang, Ping Ma, Shibao Li
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity
Moritz von Fallois, Friederike Katharina Kosyna, Markus Mandl, Yosef Landesman, Jürgen Dunst, Reinhard Depping
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review
D. Huber, S. Seitz, K. Kast, G. Emons, O. Ortmann
Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy
Zhaodong Fei, Ting Xu, Xiufang Qiu, Mengying Li, Taojun Chen, Li Li, Chaoxiong Huang, Chuanben Chen
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach
Luca Boldrini, Angela Romano, Silvia Mariani, Davide Cusumano, Francesco Catucci, Lorenzo Placidi, Gian Carlo Mattiucci, Giuditta Chiloiro, Francesco Cellini, Maria Antonietta Gambacorta, Luca Indovina, Vincenzo Valentini
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study)
Fiorenza De Rose, Maria Carmen De Santis, Bruno Meduri, Ciro Franzese, Davide Franceschini, Pierfrancesco Franco, Nadia Pasinetti, Valentina Lancellotta, Patrizia Giacobazzi, Eliana La Rocca, Elisa D’Angelo, Laura Lozza, Lorenzo Livi, Icro Meattini, Marta Scorsetti
Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients
Jinfeng Liu, Jian Hao, Yangyang Niu, Xiongzhi Wu
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020
Jens Büntzel, Oliver Micke, Michael Klein, Judith Büntzel, Stefanie Walter, Christian Keinki, Jutta Huebner
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases
Dao-Ping Sun, Wen-Ming Chen, Li Wang, Zhen Wang, Jin-Hua Liang, Hua-Yuan Zhu, Lei Fan, Yu-Jie Wu, Wei Xu, Jian-Yong Li
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center
Marie-Kristin Schwaegermann, Melanie Schranz, Markus Moehler, Christian Labenz, Alice Moringlane, Marcus Schmidt, Matthias Theobald, Georg Hess
Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study
Chuanxi Zheng, Jianguo Fang, Yitian Wang, Yong Zhou, Chongqi Tu, Li Min
Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation
Kosuke Nomura, Toshiro Iizuka, Daisuke Kaji, Yuki Asano-Mori, Yorinari Ochiai, Yugo Suzuki, Junnosuke Hayasaka, Satoshi Yamashita, Akira Matsui, Daisuke Kikuchi, Shuichi Taniguchi, Yutaka Takazawa, Shu Hoteya
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler, Murat Ayhan, Tugba Basoglu, Aysegul Ilhan, Nadiye Akdeniz, Ahmet Gulmez, Izzet Dogan, Burak Yasin Aktas, Mustafa Gurbuz, Sinan Koca, Semra Paydas, Ali Murat Tatli, Havva Yesil Cinkir, Ozkan Alan, Cihan Erol, Mutlu Hizal, Engin Kut, Serkan Menevse, Teoman Sakalar, Halil Taskaynatan, Gulhan Ipek Deniz, Mustafa Karaagac, Okan Avci, Erdem Sen, Fatih Karatas, Muhammed Bulent Akinci, Didem Sener Dede, Atakan Demir, Ahmet Demirkazık, Berna Oksuzoglu, Sadettin Kilickap, Fulden Yumuk, Bulent Yalcin
Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study
Yingcong Fan, Maoxing Liu, Shijie Li, Jianhong Yu, Xinyu Qi, Fei Tan, Kai Xu, Nan Zhang, Zhendan Yao, Hong Yang, Chenghai Zhang, Jiadi Xing, Zaozao Wang, Ming Cui, Xiangqian Su
Elotuzumab spares dendritic cell integrity and functionality
Sebastian Schlaweck, Leon Strauss, Solveig Daecke, Peter Brossart, Annkristin Heine
Letter regarding, “Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses”
Aayah Nounu, Venexia Walker, Rebecca C. Richmond
Correction to: Letter regarding, “Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses”
Aayah Nounu, Venexia Walker, Rebecca C. Richmond